Alterations in cerebral glutamic acid decarboxylase and3H-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapine

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of neural transmission

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF01244643PMID 3806083
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat

  2004cited by this paper
• Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats

  2004cited by this paper
• Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats

  2004cited by this paper
• Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia

  2004cited by this paper
• Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.

  1985cited by this paper
• Brain Biochemistry in Schizophrenia: An Assessment

  1985cited by this paper
• Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis

  1984cited by this paper
• Abnormal Involuntary Movements in Schizophrenia: Are They Related to the Disease Process or Its Treatment? Are They Associated with Changes in Dopamine Receptors?

  1982cited by this paper
• gamma-Aminobutyric acid and benzodiazepine binding sites in audiogenic seizure-susceptible mice.

  1982cited by this paper
• Radioreceptor labeling of pre- and postsynaptic dopamine receptors.

  1980cited by this paper
• Improvement in tardive dyskinesia after muscimol therapy.

  1979cited by this paper
• BRAIN BIOCHEMISTRY IN SCHIZOPHRENIA

  1978cited by this paper
• Effect of baclofen on tardive dyskinesia

  1978cited by this paper
• Turnover rates of γ-aminobutyric acid in substantia nigra, N. caudatus, globus pallidus and N. accumbens of rats injected with cataleptogenic and non-cataleptogenic antipsychotics

  1978cited by this paper
• Chronic neuroleptic therapy: tolerance and GABA systems.

  1977cited by this paper
• Effect of chronic neuroleptic or L-DOPA administration on GABA levels in the rat substantia nigra.

  1977cited by this paper
• Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses.

  1977cited by this paper
• Baclofen (Lioresal®) in the treatment of neuroleptic‐induced tardive dyskinesia

  1976cited by this paper
• Letter: Clonazepam in the treatment of drug-induced dyskinesia.

  1975cited by this paper
• Clozapine--a potential antipsychotic agent without extrapyramidal manifestations.

  1975cited by this paper
• CLOZAPINE AND HALOPERIDOL IN A SINGLE‐BLIND CROSS‐OVER TRIAL: THERAPEUTIC AND BIOCHEMICAL ASPECTS IN THE TREATMENT OF SCHIZOPHRENIA

  1974cited by this paper
• Clozapine--a potential antipsychotic agent without extrapyramidal manifestations.

  1974cited by this paper
• The pharmacology of extrapyramidal movement disorders.

  1972cited by this paper
• Some properties of L-glutamic decarboxylase in mouse brain.

  1963cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• GAD1 Gene Expression in Blood of Patients with First-Episode Psychosis

  2017cites this paper
• The effects of antipsychotic drugs on GABAA receptor binding depend on period of drug treatment and binding site examined.

  2007influential citation
• Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders.

  2006cites this paper
• Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics

  2005cites this paper
• Effect of chronic haloperidol treatment on peripheral benzodiazepine binding sites in cerebral cortex of rats

  2005cites this paper
• Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose

  2005cites this paper
• Methylazoxymethanol (MAM)-induced brain lesion and oral dyskinesia in rats

  2005cites this paper
• Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats

  2005cites this paper
• Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT‐PCR

  2003cites this paper
• Pharmacological actions of the atypical antipsychotic drug clozapine: A review

  1996cites this paper
• Delayed image of iodine-123 iomazenil as a relative map of benzodiazepine receptor binding: The optimal scan time

  1996cites this paper
• Glutamate decarboxylase messenger RNA in rat pallidum: comparison of the effects of haloperidol, clozapine and combined haloperidol-scopolamine treatments.

  1995cites this paper
• The consequences of long-term antipsychotic drug administration on basal ganglia neuronal function in laboratory animals.

  1994cites this paper
• GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatment.

  1994cites this paper
• Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic‐induced dyskinesias

  1994cites this paper
• An animal model for coexisting tardive dyskinesia and tardive parkinsonism: a glutamate hypothesis for tardive dyskinesia.

  1993cites this paper
• Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases glutamic acid decarboxylase mRNA in rat striatum.

  1993cites this paper
• CSF diazepam binding inhibitor and schizophrenia: clinical and biochemical relationships.

  1993cites this paper
• Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum: a review.

  1993cites this paper
• Clozapine and haloperidol have differential effects on glutamic acid decarboxylase mRNA in the pallidal nuclei of the rat.

  1992cites this paper
• Chronic neuroleptic administration decreases extracellular GABA in the nucleus accumbens but not in the caudate-putamen of rats.

  1992cites this paper
• Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission

  1992cites this paper
• Chronic administration of amphetamine increases glutamic acid decarboxylase activity in the rat substantia nigra.

  1990cites this paper
• Neuropeptide changes in a primate model (Cebus apella) for tardive dyskinesia.

  1990cites this paper
• Reduced glutamate decarboxylase activity in the subthalamic nucleus in patients with tardive dyskinesia

  1989cites this paper
• Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system

  1989cites this paper
• Can the supersensitivity of rodents to dopamine be regarded as a model of tardive dyskinesia?

  1989cites this paper
• Chronic melperone administration does not enhance oral movements in rats

  1989cites this paper
• Chronic pharmacological manipulation of dopamine receptors in brain.

  1987cites this paper